CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Change in control · Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · Shareholder rights changed · Other events
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Shareholder rights changed · Other events
- 8-K Event Other events
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Delisting notice
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Exit or restructuring costs · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 3 of 26 · 517 filings